Intraneuronal amyloid-β plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation

Journal of Neurochemistry

Volumn 103, Issue 3, 2007, Pages 1031-1040

  Levi, Ofir ^a   Dolev, Iftach ^a   Belinson, Haim ^a   Michaelson, Daniel M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Activated caspase 3; Apolipoprotein E4; Beta amyloid; Environmental stimulation; NeuN; TUNEL

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ELECTROENCEPHALOGRAM; ENVIRONMENT; GENOTYPE; HIPPOCAMPUS; HUMAN; MALE; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BRAIN; DENTATE GYRUS; ENVIRONMENT DESIGN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONAL PLASTICITY; NEURONS; POLYMERS; SENILE PLAQUES;

MUS; MUS MUSCULUS;

EID: 35248840007     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04810.x     Document Type: Article

References (51)

1. Arendash G. W., Garcia M. F., Costa D. A., Cracchiolo J. R., Wefes I. M. Potter H. (2004) Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15, 1751 1754.
2. Arendt T., Schindler C., Bruckner M. K., Eschrich K., Bigl V., Zedlick D. Marcova L. (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J. Neurosci. 17, 516 529.
3. Brendza R. P., Bales K. R., Paul S. M. Holtzman D. M. (2002) Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models. Mol. Psychiatry 7, 132 135.
4. Buttini M., Akeefe H., Lin C., Mahley R. W., Pitas R. E., Wyss-Coray T. Mucke L. (2000) Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97, 207 210.
5. Cirrito J. R., Yamada K. A., Finn M. B., Sloviter R. S., Bales K. R., May P. C., Schoepp D. D., Paul S. M., Mennerick S. Holtzman D. M. (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913 922.
6. Dolev I. Michaelson D. M. (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc. Natl Acad. Sci. USA 101, 13909 13914.
7. Dolev I. Michaelson D. M. (2006) The nucleation growth and reversibility of Amyloid-beta deposition in vivo. J. Alzheimers Dis. 10, 291 301.
8. Fagan A. M., Watson M., Parsadanian M., Bales K. R., Paul S. M. Holtzman D. M. (2002) Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol. Dis. 9, 305 318.
9. Gil J. M., Mohapel P., Araujo I. M., Popovic N., Li J. Y., Brundin P. Petersen A. (2005) Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol. Dis. 20, 744 751.
10. Hardy J. (2006) Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr. Alzheimer Res. 3, 71 73.
11. Hartman R. E., Wozniak D. F., Nardi A., Olney J. W., Sartorius L. Holtzman D. M. (2001) Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp. Neurol. 170, 326 344.
12. Herz J. Chen Y. (2006) Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 7, 850 859.
13. Holtzman D. M. (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J. Mol. Neurosci. 23, 247 254.
14. Jankowsky J. L., Xu G., Fromholt D., Gonzales V. Borchelt D. R. (2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 62, 1220 1227.
15. Jankowsky J. L., Melnikova T., Fadale D. J., Xu G. M., Slunt H. H., Gonzales V., Younkin L. H., Younkin S. G., Borchelt D. R. Savonenko A. V. (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 25, 5217 5224.
16. Jensen M., Hartmann T., Engvall B. et al. (2000) Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems. Mol. Med. 6, 291 302.
17. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S. Malinow R. (2003) APP processing and synaptic function. Neuron 37, 925 937.
18. Katzman R. (1993) Education and the prevalence of dementia and Alzheimer's disease. Neurology 43, 13 20.
19. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W. Glabe C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486 489.
20. Lazarov O., Robinson J., Tang Y. P., Hairston I. S., Korade-Mirnics Z., Lee V. M., Hersh L. B., Sapolsky R. M., Mirnics K. Sisodia S. S. (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701 713.
21. Lee V. M., Goedert M. Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121 1159.
22. Levi O. Michaelson D. M. (2007) Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J. Neurochem. 100, 202 210.
23. Levi O., Jongen-Relo A. L., Feldon J., Roses A. D. Michaelson D. M. (2003) ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 13, 273 282.
24. Levi O., Jongen-Relo A. L., Feldon J., Roses A. D. Michaelson D. M. (2005) Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4. J. Neurol. Sci. 15, 229 230 : 241 248.
25. Lippa C. F., Nee L. E., Mori H. St George-Hyslop P. (1998) Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease. Lancet 352, 1117 1118.
26. Mahley R. W. Huang Y. (2006) Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurol. Scand. Suppl. 185, 8 14.
27. Mahley R. W., Weisgraber K. H. Huang Y. (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 5644 5651.
28. Manelli A. M., Stine W. B., Van Eldik L. J. LaDu M. J. (2004) ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J. Mol. Neurosci. 23, 235 246.
29. Manelli A. M., Bulfinch L. C., Sullivan P. M. Ladu M. J. (2007) Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation. Neurobiol. Aging 28, 1139 1147.
30. Masters C. L. Beyreuther K. (2006) Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain 129, 2823 2839.
31. Matsumori Y., Hong S. M., Fan Y., Kayama T., Hsu C. Y., Weinstein P. R. Liu J. (2005) Enriched environment and spatial learning enhance hippocampal neurogenesis and salvages ischemic penumbra after focal cerebral ischemia. Neurobiol. Dis. 22, 187 198.
32. Mori E., Lee K., Yasuda M., Hashimoto M., Kazui H., Hirono N. Matsui M. (2002) Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann. Neurol. 51, 209 214.
33. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W. Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850 852.
34. Pasternak S. H., Callahan J. W. Mahuran D. J. (2004) The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective. J. Alzheimers Dis. 6, 53 65.
35. Pitas R. E., Ji Z. S., Weisgraber K. H. Mahley R. W. (1998) Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E. Biochem. Soc. Trans. 26, 257 262.
36. Sabo T., Lomnitski L., Nyska A., Beni S., Maronpot R. R., Shohami E., Roses A. D. Michaelson D. M. (2000) Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience 101, 879 884.
37. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D. Roses A. D. (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 9649 9653.
38. Selkoe D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741 766.
39. Selkoe D. J. Schenk D. (2003) Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545 584.
40. Teter B. (2004) ApoE-dependent plasticity in Alzheimer's disease. J. Mol. Neurosci. 23, 167 179.
41. Teter B., Xu P. T., Gilbert J. R., Roses A. D., Galasko D. Cole G. M. (1999) Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J. Neurochem. 73, 2613 2616.
42. Ting J. T., Kelley B. G., Lambert T. J., Cook D. G. Sullivan J. M. (2007) Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc. Natl Acad. Sci. USA 104, 353 358.
43. Van Praag H., Kempermann G. Gage F. H. (2000) Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 1, 191 198.
44. White F., Nicoll J. A., Roses A. D. Horsburgh K. (2001) Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol. Dis. 8, 611 625.
45. Willis S. L., Tennstedt S. L., Marsiske M. et al. (2006) Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 296, 2805 2814.
46. Wisniewski T., Golabek A., Matsubara E., Ghiso J. Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Commun. 192, 359 365.
47. Wolf S. A., Kronenberg G., Lehmann K., Blankenship A., Overall R., Staufenbiel M. Kempermann G. (2006) Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol. Psychiatry 60, 1314 1323.
48. Xu P. T., Schmechel D., Rothrock-Christian T. et al. (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3, 229 245.
49. Ye S., Huang Y., Mullendorff K., Dong L., Giedt G., Meng E. C., Cohen F. E., Kuntz I. D., Weisgraber K. H. Mahley R. W. (2005) Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc. Natl Acad. Sci. USA 102, 18700 18705.
50. Young D., Lawlor P. A., Leone P., Dragunow M. During M. J. (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat. Med. 5, 448 453.
51. Zerbinatti C. V. Bu G. (2005) LRP and Alzheimer's disease. Rev. Neurosci. 16, 123 135.